Novavax, Inc. (NVAX)
NASDAQ: NVAX · IEX Real-Time Price · USD
13.85
-1.11 (-7.42%)
At close: Jul 19, 2024, 4:00 PM
14.09
+0.24 (1.73%)
Pre-market: Jul 22, 2024, 7:33 AM EDT
Novavax Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for Novavax stock have an average target of 19, with a low estimate of 10 and a high estimate of 29. The average target predicts an increase of 37.18% from the current stock price of 13.85.
Analyst Consensus: Buy
* Price targets were last updated on Jun 14, 2024.
Analyst Ratings
The average analyst rating for Novavax stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 2 | 2 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 2 | 2 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
B of A Securities | B of A Securities | Hold Maintains $12 → $18 | Hold | Maintains | $12 → $18 | +29.96% | Jun 14, 2024 |
B. Riley Securities | B. Riley Securities | Strong Buy Maintains $11 → $29 | Strong Buy | Maintains | $11 → $29 | +109.39% | May 23, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +37.18% | May 13, 2024 |
TD Cowen | TD Cowen | Hold Maintains $5 → $10 | Hold | Maintains | $5 → $10 | -27.80% | May 13, 2024 |
B of A Securities | B of A Securities | Sell → Hold Upgrades $4 → $12 | Sell → Hold | Upgrades | $4 → $12 | -13.36% | May 10, 2024 |
Financial Forecast
Revenue This Year
1.02B
from 983.71M
Increased by 3.18%
Revenue Next Year
431.20M
from 1.02B
Decreased by -57.52%
EPS This Year
0.49
from -5.41
EPS Next Year
-0.77
from 0.49
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.2B | 632.0M | 720.5M | 827.6M | 1.2B |
Avg | 1.0B | 431.2M | 414.5M | 617.8M | 873.9M |
Low | 793.8M | 49.0M | 27.4M | 415.6M | 483.8M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 20.9% | -37.7% | 67.1% | 99.7% | 92.5% |
Avg | 3.2% | -57.5% | -3.9% | 49.1% | 41.5% |
Low | -19.3% | -95.2% | -93.6% | 0.3% | -21.7% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.95 | 0.19 | 2.16 | 1.16 | 1.66 |
Avg | 0.49 | -0.77 | 0.01 | 0.16 | 0.58 |
Low | -1.19 | -2.14 | -1.45 | -0.76 | -0.44 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | -61.4% | - | 14,998.0% | 916.5% |
Avg | - | - | - | 2,033.3% | 253.1% |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.